Transaxillary Breast Augmentation: A Prospective Comparison of Subglandular, Subfascial, and Submuscular Implant Insertion.
Aesthetic Plast Surg. 2009 Jul 14; Pereira LH, Sterodimas ABACKGROUND: During the last decades transaxillary breast augmentation (TBA) has gained worldwide acceptance. Breast augmentation via transaxillary access endoscopically assisted in the subglandular, subfascial, and submuscular planes has been previously described. Although TBA is a well-studied procedure, few reports exist concerning the subfascial plane of implant insertion and none exist comparing the three different planes of insertion by TBA. METHODS: A perspective study to evaluate the outcomes, complications, and patient satisfaction of TBA using the three different planes of implant insertion was performed during 2004-2005. Fifty-three patients fulfilled the inclusion criteria. They were randomly divided into three groups corresponding to the three planes of silicone insertion. All patients had a silicone texturized implant that ranged from 190 to 300 cc. Overall satisfaction with the breast appearance after TBA was rated on a scale of 1-5, where 1 is poor, 2 is fair, 3 is good, 4 is very good, and 5 is excellent. The evaluation was made at the follow-up times of 6 months and 3 years. RESULTS: There were 18 patients enrolled for the subcutaneous TBA (Group A), 18 for the subfascial TBA (Group B), and 17 for the submuscular TBA (Group C). Axillary incision-related complications occurred in 9% of the patients and included formation of a hypertrophic scar and small-wound dehiscence. There was no hematoma formation and no case of infection. There was one patient from Group A who developed seroma and was treated conservatively. Twenty-seven months postoperatively the same patient developed Baker III capsule contracture, which required silicone implant replacement in the subfascial plane. One case of stretch marks in a young nulliparous woman from Group B did not need treatment. One patient from Group A underwent implant exchange because of implant size dissatisfaction. Three patients in Group C had mild distortion of the implant during pectoral contracture. A meta-analysis of patient satisfaction 6 months and 3 years after TBA is presented. CONCLUSION: Transaxillary breast augmentation provides consistent, satisfactory results with ease of dissection, when properly indicated. Although the subfascial augmentation mammaplasty has all the advantages of the subpectoral and subglandular augmentation mammaplasties and eliminates the disadvantages of increased postoperative discomfort, implant visibility, and distortion, patients of all three groups had similar rates of satisfaction. Further follow-up is needed in order to compare the long-term effects of the three different planes of insertion.
[Inhibitory effect of human Col I A1 antisense oligodeoxyneucleotide on collagen synthesis in hypertrophic scar fibroblasts]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009 Jun; 23(6): 713-7Yuan J, Li T, Qi SOBJECTIVE: To investigate the inhibitory effect of Col I A1 antisense oligodeoxyneucleotide (ASODN) transfection mediated by cationic liposome on Col I A1 expression in human hypertrophic scar fibroblasts. METHODS: Scar tissue was obtained from volunteer donor. Human hypertrophic scar fibroblasts were cultured by tissue block method. The cells at passage 4 were seeded in a 6 well cell culture plate at 32.25 x 10(4) cells/well, and then divided into 4 groups: group A, liposome and Col I A1 ASODN; group B, Col I A1 ASODN; group C, liposome; group D, blank control. At 8 hours, 1, 2, 3 and 4 days after transfection, total RNA of the cells were extracted, the expression level of Col I A1 mRNA was detected by RT-PCR, the Col I A1 protein in ECM was extracted by pepsin-digestion method, its concentration was detected by ELISA method. RESULTS: Agarose gel electrophoresis detection of amplified products showed clear bands without occurrence of indistinct band, obvious primer dimmer and tailing phenomenon. Relative expression level of Col I A1 mRNA: at 8 hours after transfection, group A was less than groups B, C and D (P < 0.05), and groups B and C were less than group D (P < 0.05), and no significant difference was evident between group B and group C (P > 0.05); at 1 day after transfection, groups A and B were less than groups C and D (P < 0.05), and there was no significant difference between group A and group B, and between group C and group D (P > 0.05 ); at 2 days after transfection, there were significant differences among four groups (P < 0.05); at 3 and 4 days after transfection, group A was less than groups B, C and D (P < 0.05), group B was less than groups C and D (P < 0.05), and no significant difference was evident between group C and group D (P > 0.05). Concentration of Col I protein: at 8 hours after transfection, group A was less than groups B, C and D (P < 0.05), groups B and C were less than group D (P < 0.05), and no significant difference was evident between group B and group C (P > 0.05); at 1 day after transfection, significant differences were evident among four groups (P < 0.05); at 2, 3 and 4 days after tranfection, groups A and B were less than groups C and D (P < 0.05), and no significant difference was evident between group A and group B (P > 0.05). CONCLUSION: Col I A1 ASODN can inhibit mRNA and protein expression level of Col I A1. Cationic liposome, as the carrier, can enhance the inhibition by facilitating the entry of ASODN into cells and introducing ASODN into cell nucleus.
Multiwalled carbon nanotube buckypaper: toxicology and biological effects in vitro and in vivo.
Nanomed. 2009 Jul; 4(5): 531-540Bellucci S, Chiaretti M, Cucina A, Carru G, Chiaretti AAim: We evaluated the effect of buckypaper (BP) on cancer and primary cell lines in vitro and in vivo in laboratory rats. BP is an innovative material with interesting physical/chemical properties that has possible pharmacological and prosthetic employment. Given that precautions need to be taken where carbon nanotubes are injected into human body for drug delivery, as contrast agent-carrying entities for MRI or as the material of a new prosthesis generation, we assessed the toxicity of BP carbon nanotubes. BP has structural resemblance to asbestos, whose toxicity has been linked to cancer. Results: BP decreased proliferation of human colorectal, breast and leukemic cancer cell lines in vitro. However, BP had no effect on the proliferation and viability of normal human arterial smooth muscle cells and human dermal fibroblasts in vitro. in vivo, BP induced a moderate inflammatory reaction but had no mutagenic effects. After BP implantation the animals showed an inflammatory reaction followed 2 weeks later by a cicatrization reaction with the organization and fibrosis of the scar. Conclusion: These results show a low toxicity of BP both in vitro and in vivo.
Non-fibrillar collagens: Key mediators of post-infarction cardiac remodeling?
J Mol Cell Cardiol. 2009 Jun 29; Shamhart PE, Meszaros JGCardiac remodeling is accelerated during pathological conditions and several anabolic and catabolic regulators work in concert to repair the myocardium and maintain its functionality. The fibroblasts play a major role in this process via collagen deposition as well as supplying the degradative matrix metalloproteinases. During the more acute responses to a myocardial infarction (MI) the heart relies on a more aggressive wound healing sequence that includes the myofibroblasts, specialized secretory cells necessary for infarct scar formation and thus, rescue of the myocardium. The activated fibroblasts and myofibroblasts deposit large amounts of fibrillar collagen during the post-MI wound healing phase, type I and III collagen are the most abundant collagens in the heart and they maintain the structural integrity under normal and disease states. While collagen I and III have been the traditional focus of the myocardial matrix, recent studies have suggested that the non-fibrillar collagens (types IV and VI) are also deposited during pathological wound healing and may play key roles in myofibroblast differentiation and organization of the fibrillar collagen network. This review highlights the potential roles of the non-fibrillar collagens and how they work in concert with the fibrillar collagens mediate myocardial remodeling.